Key result
Decreased aVL R-wave amplitude after CRT predicts MR improvement and better long-term survival.
Why the study?
Reduction in RaVL often occurs after CRT alongside shorter QRS duration and reduced MR, prompting evaluation of whether RaVL changes reflect PM resynchronization and predict MR severity, clinical response, and survival.
Does a reduction in R-wave amplitude in lead aVL after cardiac resynchronization therapy predict mitral regurgitation improvement and long-term survival?
Cohort (n=231)
Does a reduction in R-wave amplitude in lead aVL after cardiac resynchronization therapy predict mitral regurgitation improvement and long-term survival?
Answers are grounded in this paper and cite their sources.
A decrease in R-wave amplitude in lead aVL following CRT implantation serves as a simple electrocardiographic predictor of improved mitral regurgitation and long-term survival.
Background: Reduction in R-wave amplitude in lead aVL (RaVL) is often noted after cardiac resynchronization therapy (CRT), together with a shorter QRS duration and reduced mitral regurgitation (MR). Given that lead aVL reflects electrical activity in the anterolateral left ventricular wall, where the anterolateral papillary muscle (PM) resides, opposing the posteromedial one, we hypothesized that these electrocardiographic changes may reflect improved electrical resynchronization of the PMs, contributing to MR reduction. Objective: This study aimed to evaluate the relationship between post-CRT changes in RaVL and MR severity and assess whether RaVL can serve as a surface electrocardiographic marker of PM dyssynchrony and a predictor of clinical response and long-term survival. Methods: We analyzed 231 patients who underwent CRT implantation and were followed for a median of 41 months (interquartile range 29-55); 88 patients died during this period. Patients who experienced a reduction in RaVL or a decrease in QRS duration after CRT had significantly better survival than those whose corresponding parameters remained unchanged or increased. Both variables independently predicted survival in multivariable Cox regression. Conclusion: A decrease in RaVL after CRT predicts MR improvement and survival, likely reflecting improved PM synchronization and mechanical resynchronization.
No takes yet. Share an insight, caveat, or question.
Eötvös et al. (2025) conducted a cohort in Patients undergoing cardiac resynchronization therapy (n=231). Decrease in R-wave amplitude in lead aVL (RaVL) after CRT vs. Unchanged or increased RaVL after CRT was evaluated on Mitral regurgitation response and long-term survival (p=<.0001). A decrease in R-wave amplitude in lead aVL after CRT independently predicted mitral regurgitation improvement and better long-term survival compared to unchanged or increased amplitude.
Synapse has enriched 10 related papers. Consider them for comparative context: